Found "Vaccines": 77 results
WORKSHOP ON VACCINE ECONOMICS AND FOLLOW-UP ON HTA STUDIES
The International Decision Support Initiative (iDSI) lead by Health Intervention Technology Assessment Program (HITAP) has been working closely with the Health Technology Assessment Committee (HTAC) the nodal agency responsible for health technology assessment (HTA) under the Ministry of Health, Ind
Economic Evaluation of Rotavirus Vaccine in Bhutan
Bhutan is a rapidly growing economy that is transitioning from international donor support. As such, the country is looking for ways to ensure that they continue to provide the adequate services and support for their population in a rational and sustainable manner. Bhutan has begun using health tech
Christian Medical College (CMC) Vellore Research Internship to HITAP
This report aims to describe the study visit of researchers at Christian Medical College (CMC) Vellore who are undertaking cost of illness studies on enteric fever and rotavirus vaccines in India at the Health Intervention and Technology Assessment Program (HITAP). HITAP, known regionally for suppor
A Course on Vaccinology for Clinical and Public Health Practice: Policy Symposium and Workshop
This course was organised at the request of Prof. Rakesh Aggarwal, the Director of JIPMER and Prof. Gagandeep Kang, the Executive Director of THSTI and Professor at the Christian Medical College (CMC) in Vellore, India. The main objective of the course was to build technical capacity of stakeholders
Mission Report: Stakeholder Consultation Meeting on Pneumococcal Conjugate Vaccine (PCV) Project in Bhutan
Bhutan achieved Universal Child Immunization in 1991 and has maintained high immunization coverage over the past decades. Since Bhutan transitioned from Gavi support in 2016 after the country’s economic classification changed to lower‐middle income country, the government is now responsible for allo
Human Papillomavirus Vaccine introduction in low and middle Income countries guidance on the use of Cost-effectiveness models.(2011)
Human papillomavirus vaccine introduction in low and middle income countries: guidance on the use of cost-effectiveness models
Mark Jit1, Nadia Demarteau2†, Elamin Elbasha3†, Gary Ginsberg4†, Jane Kim5†, Naiyana Praditsitthikorn6†, Edina Sinanovic7† and Raymond Hutubessy8*
† Contributed equally
8
Economic Evaluation of Policy Options for Prevention and Control of Cervical Cancer in Thailand.(2011)
Economic Evaluation of Policy Options for Prevention and Control of Cervical Cancer in Thailand
Naiyana Praditsitthikorn,1,2 Yot Teerawattananon,1,3 Sripen Tantivess,1,3 Supon Limwattananon,3 Arthorn Riewpaiboon,2 Saibua Chichareon,4
Nantakan Ieumwananonthachai5 and Viroj Tangcharoensathien3
Systematic Review of Economic Evaluations of Preparedness Strategies and Interventions against Influenza Pandemics
Systematic Review of Economic Evaluations of Preparedness Strategies and Interventions against Influenza Pandemics.
Roma´n Pe´ rez Velasco1*, Naiyana Praditsitthikorn1, Kamonthip Wichmann1, Adun Mohara1, Surachai Kotirum1, Sripen Tantivess1, Constanza Vallenas2, Hande Harmanci2, Yot Teerawattanan
Cost-utility analysis of 10- and 13-valent pneumococcal conjugate vaccines: Protection at what price in the Thai context? (2013)
Cost-utility analysis of 10- and 13-valent pneumococcal conjugate vaccines: Protection at what price in the Thai context?
Wantanee Kulpenga, b, , , , Pattara Leelahavaronga, , Waranya Rattanavipaponga, , Vorasith Sornsrivichaib, , Henry C. Baggettc, , Aronrag Meeyaia, d, , , Warunee Punpaniche, ,
A learning experience from price negotiations for vaccines
Full text can be accessed from:
http://www.sciencedirect.com/science/article/pii/S0264410X14017058
10 / Page